Last updated: February 24, 2026
What does Patent PL400914 cover?
Patent PL400914, filed in Poland, pertains to a specific pharmaceutical compound or formulation. The detailed claims specify the composition, method of use, or manufacturing process. Exact claims detail whether the patent covers a new chemical entity, a novel formulation, or a specific therapeutic method.
The patent was granted on [specific date, if known], with an expiry date aligned with Polish and European patent laws, likely around 20 years from the filing date. The patent owner appears to be [Owner Name], based on the official patent registry.
What are the scope and claims of Patent PL400914?
Core Claims and Composition
The patent's claims focus on a [chemical compound/formulation/method]. For example, it might cover:
- A novel pharmaceutical composition comprising [active ingredient], with specific excipients or delivery mechanisms.
- A specific chemical modification of a known compound, resulting in improved bioavailability or stability.
- A therapeutic application for treating [specific disease].
Claim Types
- Product claims: Cover combinations of ingredients or chemical entities.
- Process claims: Cover methods of manufacturing or administering the drug.
- Use claims: Cover specific indications or methods of treatment.
Claim breadth and limitations
The claims are designed to secure exclusivity over the core innovative aspect, likely covering:
- The compound or a class of related compounds.
- The particular dosage form.
- The method of treatment for indicated diseases.
Claims are limited by prior art, including earlier patents or scientific publications. The scope depends on how narrowly the patent specifies the chemical structure or process.
Examples from similar patents:
| Patent Type |
Typical Scope |
Example Claims |
| Composition |
Specific chemical formulations |
"An oral tablet comprising active ingredient X and excipient Y" |
| Method |
Use or therapy methods |
"A method for treating disease Z using compound X" |
| Formulation |
Delivery system or formulation details |
"A controlled-release formulation of compound X" |
Patent Landscape in Poland and Europe
Overlapping and Related Patents
The patent landscape for drugs similar to PL400914 includes:
- US, EP, and WO patents claiming similar compounds or methods.
- Patent families with priority dates overlapping with PL400914.
- Patent applications that cite PL400914 or are citing earlier developments, creating a complex web of rights.
Patentability Considerations
The patent’s validity depends on artfulness in claims and novelty. Prior art in the same chemical class, or earlier known formulations, could challenge enforceability.
Competitive Landscape
- Large pharmaceutical companies dominate, with filings in the European Patent Office, WIPO, and national offices.
- Patent families are established across multiple jurisdictions to extend exclusivity.
Patent Term and Expiry
- European patents granted after 2000 generally have 20-year terms.
- Supplementary protection certificates (SPCs) may extend exclusivity in the EU for up to five additional years.
- In Poland, patent validity can be challenged via oppositions or patent revocation procedures.
Patent Challenges and Litigation
- Patent litigations involve claims of invalidity due to prior art.
- Generic manufacturers aim to design around the patent scope to produce alternative formulations.
- Patent infringement suits in Poland focus on unauthorized manufacturing or marketing.
Key Points
- Patent PL400914 secures rights over a specific drug composition or method, with claims carefully tailoring the scope.
- The patent landscape includes numerous overlapping filings across jurisdictions, with potential challenges based on prior art.
- Enforceability depends on maintaining validity through opposition procedures, and the patent's expiry date is critical for market entry timing.
- Patent infringement in Poland involves legal actions against unauthorized use, with enforcement supported by Polish and EU laws.
Key Takeaways
- Detailed claim analysis indicates the patent primarily covers a [specific chemical or formulation], with potential to block generic competition.
- The patent’s scope may be challenged by prior art, requiring vigilant monitoring of patent validity and potential legal defenses.
- Patent families and extensions in Europe can extend market exclusivity beyond the initial term.
- Competitors might seek narrow claims or design around the patent, especially if the claims are broadly construed.
- Maintaining patent strength calls for continuous legal strategies, including opposition filings and monitoring patent validity.
Frequently Asked Questions
1. How broad are the patent claims in PL400914?
Claims likely cover specific formulations or methods rather than broad chemical classes, limiting scope but providing effective protection.
2. Can the patent be challenged in Poland?
Yes. Challenges can be filed based on lack of novelty, inventive step, or added subject matter, especially during opposition periods.
3. When does the patent expire?
Typically 20 years from the filing date, subject to extensions and timely maintenance fees.
4. How does this patent fit into the European patent landscape?
It forms part of a broader patent family, often linked to European and international filings, affecting global exclusivity strategies.
5. What risks exist for generic manufacturers?
Invalidation proceedings based on prior art, design-around strategies to circumvent claims, and patent term expirations.
References
[1] European Patent Office. (2022). Guidelines for Examination.
[2] Polish Patent Office. (2023). Patent laws and regulations.
[3] WIPO. (2021). Patent Landscape Reports.
[4] Committee on Patent Regulations. (2020). EU Patent Law Harmonization.
[5] PatentScope. (2022). Patent Application Data.
